anti-dementia patch
Scope
Date
~
-
Steel
POSCO to sell entire stake in Nippon Steel, ending equity ties
POSCO Holdings Inc. has decided to sell its entire stake in Nippon Steel Corp., according to industry sources on Wednesday, marking the end of their...
Mar 20, 2025 (Gmt+09:00)
-
Steel
Dongkuk to file anti-dumping petition vs Chinese color steel imports
Dongkuk Coated Metal Co. and SeAh Steel Corp. are set to file an anti-dumping complaint against Chinese rivals in March as the country plans to impo...
Feb 27, 2025 (Gmt+09:00)
-
Steel
South Korea to levy 38% anti-dumping duties on Chinese steel products
South Korea plans to impose up to 38% provisional anti-dumping duties on Chinese hot-rolled steel plates starting next month, judging that those pro...
Feb 20, 2025 (Gmt+09:00)
-
Steel
Korea to probe Chinese, Japanese steel imports over anti-dumping claims
South Korea is set to launch an anti-dumping investigation into hot-rolled steel imports from China and Japan, according to government and industry ...
Feb 19, 2025 (Gmt+09:00)
-
Steel
South Korea’s steel imports from China at 7-year high
South Korea’s imports of steel products from China climbed to their highest level in seven years despite a decrease in its total steel imports...
Jan 13, 2025 (Gmt+09:00)
-
Paper
Korean paper makers to file anti-dumping complaint vs Japanese rivals
South Korean corrugated cardboard sheet makers such as Asia Paper Manufacturing Co. have decided to file an anti-dumping complaint against Japanese ...
Dec 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Nov 21, 2024 (Gmt+09:00)
-
Energy
Czech anti-trust body puts signing of nuclear power deal on hold
The Czech anti-trust body put a temporary block on the conclusion of a contract with Korea Hydro & Nuclear Power Co. (KHNP) for the construction...
Oct 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Oct 11, 2024 (Gmt+09:00)
-
Business & Politics
South Korea scraps anti-nuclear policy with approval of two nuclear plants
South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...
Sep 13, 2024 (Gmt+09:00)
-
Chemical Industry
Samhwa Paint launches anti-rust product Knok-Stop
South Korea's Samhwa Paint Industrial said on Wednesday that it has introduced a new water-based primer, Knok-Stop, designed to convert rust on meta...
Aug 22, 2024 (Gmt+09:00)
-
Regulations
S.Korea, China's technology leak, anti-dumping disputes surge
South Korean companies are getting tough on anti-dumping and patent infringement cases as they feel threatened by the intensifying price competition...
Aug 02, 2024 (Gmt+09:00)
-
ESG
LG Energy Solution acquires anti-bribery certification
South Korea's LG Energy Solution Ltd. announced on Thursday that it achieved ISO 37001 certification, an international standard for anti-bribery man...
Jul 11, 2024 (Gmt+09:00)
-
Chemical Industry
Lotte Chemical develops anti-thermal runaway material
Lotte Chemical Corp., South Korea’s second-largest petrochemicals company seeking to ramp up value-added advanced materials production, has de...
Jun 20, 2024 (Gmt+09:00)
-
E-commerce
Coupang fined $102 mn for alleged search algorithm manipulation
Coupang Inc., South Korea’s largest e-commerce platform, was fined 140 billion won ($102 million) on Thursday for allegedly manipulating searc...
Jun 13, 2024 (Gmt+09:00)
-
Bio & Pharma
S.Korean anti-obesity drugmakers eye niche demand
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...
May 07, 2024 (Gmt+09:00)
-
Steel
Korean steelmakers mull anti-dumping suit vs Chinese, Japanese firms
Under growing pressure from increased imports of cheap Chinese and Japanese steel products, South Korean steelmakers are considering filing an anti-...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Aerospace & Defense
Hanwha wins S.Korean military anti-drone system deals
South Korean aerospace and defense maker Hanwha Systems Co. is set to establish a military system to cope with small unmanned aerial vehicles (UAVs)...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai builds Aegis destroyer with anti-ballistic missiles
ULSAN, South Korea – At the shipyard of HD Hyundai Heavy Industries Co. on Nov. 20 in Ulsan, South Gyeongsang Province, South Korea's ne...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Regulations
Korea’s antitrust body grants conditional OK to Broadcom-VMware deal
South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
The KED View
Five most common frustrations of Korean entrepreneurs
A South Korean company recently gave up on its plan to venture into the burgeoning robot market.Fair-trade regulations that prohibit the creation of...
Oct 12, 2023 (Gmt+09:00)
-
Artificial intelligence
Vuno's brain imaging AI medical device secures FDA certification
South Korea's medical device startup Vuno announced on Tuesday that its AI-powered brain quantification device Vuno Med-DeepBrain has received the 5...
Oct 10, 2023 (Gmt+09:00)
-
Steel
Japanese steelmakers flood South Korea on back of weaker yen
Japanese steelmakers are expanding their market shares in South Korea, backed by the yen's drop against the Korean won to the lowest in eight years....
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand